InterSpace Knee Extra-Large Size, InterSpace Knee ATS
510(k) K181732
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK181732 | Date27 Apr 2019 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- JWH
- Device Class
- Class II
- Regulation
- 21 CFR Part 888.3560
- Advisory Committee
- Orthopedic
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 21 Sep 2026
The InterSpace Knee Extra-Large Size, InterSpace Knee ATS is a knee joint patellofemorotibial polymer semi-constrained device. It is indicated for temporary use (maximum 180 days) as a total knee replacement (TKR) in skeletally mature patients undergoing a two-stage procedure due to a septic process, or as an adjunct to total knee replacement in such patients.
The device is supplied by Tecres S.p.A. and was cleared through the FDA 510(k) process under K-number K181732. It is intended for temporary implantation and is not designed for long-term use. No information regarding sterility, single-use or reusable status, MRI safety, storage conditions, or additional sizes is provided in the data.
Other devices from Tecres S.p.A.
Questions
AI-generated answers, 21 Sep 2026
What is the InterSpace Knee Extra-Large Size ATS used for?
It is indicated for temporary use (maximum 180 days) as a total knee replacement in skeletally mature patients undergoing a two-stage procedure due to a septic process, or as an adjunct to total knee replacement in such patients. This is based on its intended use as a temporary implant to manage infection while preserving joint function during staged revision.
How is the InterSpace Knee Extra-Large Size ATS supplied and what is its intended duration of use?
The device is supplied by Tecres S.p.A. and is intended for temporary implantation only, with a maximum use duration of 180 days. It is not designed for long-term use, as explicitly stated in the device description, to avoid complications from prolonged polymer implantation in infected fields.
What regulatory pathway was used for the InterSpace Knee Extra-Large Size ATS and what is its K-number?
The device was cleared through the FDA 510(k) process under K-number K181732, as stated in the authorizations and specifications. This indicates it was found substantially equivalent to a predicate device, which is the basis for its market authorization in the U.S.